Related Experiment Video
Updated: May 16, 2026
07:20
Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Latest advances in biomarker discovery and development.
1Thomson Reuters, Barcelona, Spain. michelle.tracy@thomsonreuters.com
Drugs of Today (Barcelona, Spain : 1998)
|November 22, 2012
Summary
This congress highlighted the crucial role of biomarkers in drug discovery and development. Experts discussed various biomarker applications, from diagnostics to patient selection, emphasizing their impact on therapeutic advancements.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- The 7th Annual Biomarkers Congress convened experts in biomarker applications for drug discovery.
- Attendees represented academia, industry, and service providers in biomarker assay development and sample analysis.
- The congress focused on diverse biomarker types and their applications across the drug development pipeline.
Purpose of the Study:
- To explore the latest advancements in biomarker discovery and development.
- To discuss the application of biomarkers in drug discovery, clinical qualification, and analytical validation.
- To foster collaboration and knowledge exchange among professionals in the biomarker field.
Main Methods:
- Presentations covered the full spectrum of biomarker development, from discovery to clinical validation.
- Discussions included prognostic, diagnostic, predictive, and safety biomarkers.
- Case studies focused on oncology and inflammatory diseases, highlighting biomarker utility.
Main Results:
- Biomarkers are integral to modern drug discovery and development strategies.
- Diverse applications include patient selection, treatment monitoring, and safety assessment.
- Oncology and inflammatory diseases serve as key areas for biomarker application and validation.
Conclusions:
- Biomarker research and application are critical for advancing pharmaceutical R&D.
- Continued innovation in biomarker technologies is essential for personalized medicine.
- Cross-disciplinary collaboration accelerates the translation of biomarkers into clinical practice.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:19MALDI-TOF Mass Spectrometry
Mass spectrometry is a powerful characterization technique that can identify and separate a wide variety of compounds ranging from chemical to biological entities, based on their mass-to-charge ratio (m/z). The instruments that allow this detection, known as mass spectrometers, have three components: an ion source, a mass analyzer, and a detector. These spectrometers differ based on the nature of their ion source and analyzers.Matrix-assisted laser desorption ionization (MALDI) is a commonly...